Related Experiment Video
Updated: Jun 14, 2025
09:01
Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
Published on: January 27, 2023
1.6K
Vascular Calcification: Where is the Cure?
1Department of Geriatrics, Peking University First Hospital, Beijing 100034, China.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih
|September 4, 2024
Summary
Vascular calcification (VC) increases with age, linked to poor health outcomes. Current treatments for VC lack clinical effectiveness, highlighting the need for novel therapeutic strategies.
Area of Science:
- Biomedical research
- Cardiovascular science
- Aging research
Background:
- Vascular calcification (VC) incidence rises with aging.
- VC is associated with increased cardiovascular events and mortality.
- Existing interventions for VC have not demonstrated clinical effectiveness in reversal or cure.
Purpose of the Study:
- To review novel perspectives on vascular calcification interventions.
- To provide a reference for clinical decision-making regarding VC treatment.
Main Methods:
- Literature review of recent advancements in VC research.
- Analysis of emerging therapeutic targets and strategies for VC.
Main Results:
- Current interventions for VC show limited success in clinical practice.
- Several novel approaches targeting VC pathogenesis are under investigation.
Conclusions:
- There is a critical need for effective treatments to reverse or cure vascular calcification.
- This review synthesizes new insights to guide future clinical strategies for managing VC.
Related Concept Videos
01:23Antihypertensive Drugs: Vasodilators
492
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
492
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
464
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
147
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
147
01:16Vascular Spasm
1.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.3K
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
473
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
473